Wenqi Li

机构：Tianjin First Center Hospital, Tianjin Medical University · ORCID：0000-0001-8637-975X

发表论文 93 篇 · 总被引 1391 次 · h-index 20

代表论文

• Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells (2023 · Nature · 被引 135)
• Precision design of crystalline COF nanoplatforms: Revolutionizing biosensing paradigms in agri-food quality control and safety assurance (2025 · Coordination Chemistry Reviews · 被引 50)
• Nerandomilast Improves Bleomycin-Induced Systemic Sclerosis-Associated Interstitial Lung Disease in Mice by Regulating the TGF-β1 Pathway (2024 · Inflammation · 被引 18)
• Uncovering therapeutic targets for macrophage-mediated T cell suppression and PD-L1 therapy sensitization (2024 · Cell Reports Medicine · 被引 15)
• Src tyrosine kinase promotes cardiac remodeling induced by chronic sympathetic activation (2023 · Bioscience Reports · 被引 13)
• Miglustat ameliorates isoproterenol-induced cardiac fibrosis via targeting UGCG (2025 · Molecular Medicine · 被引 10)